X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15534) 15534
Newsletter (429) 429
Book Chapter (124) 124
Newspaper Article (107) 107
Magazine Article (85) 85
Dissertation (40) 40
Conference Proceeding (21) 21
Web Resource (10) 10
Publication (8) 8
Book / eBook (5) 5
Government Document (4) 4
Paper (2) 2
Streaming Video (2) 2
Book Review (1) 1
Reference (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11140) 11140
science & technology (9230) 9230
life sciences & biomedicine (8866) 8866
ribavirin (7926) 7926
ribavirin - therapeutic use (7387) 7387
antiviral agents - therapeutic use (6853) 6853
male (6423) 6423
female (6163) 6163
hepatitis c, chronic - drug therapy (6058) 6058
middle aged (5254) 5254
drug therapy, combination (5236) 5236
hepatitis c (4907) 4907
adult (4790) 4790
interferon-alpha - therapeutic use (4650) 4650
treatment outcome (3860) 3860
interferon (3746) 3746
gastroenterology & hepatology (3543) 3543
hepatitis c virus (3473) 3473
ribavirin - administration & dosage (3164) 3164
recombinant proteins (3145) 3145
hepacivirus - genetics (3043) 3043
genotype (2721) 2721
antiviral agents - administration & dosage (2706) 2706
polyethylene glycols - therapeutic use (2692) 2692
aged (2303) 2303
hepatitis c - drug therapy (2247) 2247
antiviral agents - adverse effects (2223) 2223
ribavirin - adverse effects (2095) 2095
interferon-alpha - administration & dosage (2072) 2072
hepatitis c, chronic - virology (1934) 1934
infectious diseases (1904) 1904
health aspects (1877) 1877
hepatitis (1874) 1874
hepacivirus - drug effects (1741) 1741
virology (1716) 1716
biological response modifiers (1630) 1630
interferon-alpha - adverse effects (1600) 1600
viral load (1517) 1517
pharmacology & pharmacy (1497) 1497
care and treatment (1494) 1494
ribavirin - pharmacology (1484) 1484
drug therapy (1449) 1449
antiviral agents (1418) 1418
recombinant proteins - therapeutic use (1355) 1355
animals (1304) 1304
hepatitis c, chronic - complications (1285) 1285
virus diseases (1254) 1254
rna, viral - blood (1229) 1229
chronic hepatitis c (1219) 1219
polyethylene glycols - administration & dosage (1213) 1213
antiviral agents - pharmacology (1209) 1209
viruses (1165) 1165
genetic aspects (1094) 1094
interferons - therapeutic use (1073) 1073
analysis (1071) 1071
retrospective studies (1034) 1034
abridged index medicus (1032) 1032
research (1017) 1017
time factors (990) 990
infections (987) 987
immunology (930) 930
liver (910) 910
risk factors (895) 895
polyethylene glycols - adverse effects (867) 867
patients (837) 837
prospective studies (829) 829
genotypes (822) 822
general & internal medicine (811) 811
adolescent (810) 810
hepacivirus - isolation & purification (806) 806
young adult (792) 792
medicine, general & internal (781) 781
microbiology (770) 770
recurrence (767) 767
hepatitis c, chronic - genetics (734) 734
hcv (728) 728
hiv infections - complications (725) 725
gastroenterology and hepatology (713) 713
hepatitis c - complications (707) 707
cirrhosis (688) 688
genotype & phenotype (669) 669
pegylated interferon (656) 656
digestive system diseases (644) 644
hepatitis c - virology (637) 637
polyethylene glycols (636) 636
liver cirrhosis (631) 631
dose-response relationship, drug (617) 617
liver transplantation (611) 611
hepatology (592) 592
drug administration schedule (588) 588
transplantation (588) 588
follow-up studies (586) 586
medical research (577) 577
interferon alpha-2 (574) 574
recombinant proteins - administration & dosage (571) 571
rna (571) 571
medicine (567) 567
hiv infections - drug therapy (562) 562
hepatitis c, chronic - blood (551) 551
hepatitis c, chronic - diagnosis (547) 547
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14800) 14800
Spanish (294) 294
Japanese (279) 279
French (257) 257
German (222) 222
Korean (198) 198
Russian (179) 179
Portuguese (171) 171
Chinese (163) 163
Polish (106) 106
Hungarian (60) 60
Italian (49) 49
Czech (48) 48
Turkish (23) 23
Croatian (18) 18
Serbian (16) 16
Dutch (12) 12
Danish (8) 8
Hebrew (6) 6
Finnish (5) 5
Slovak (5) 5
Swedish (5) 5
Norwegian (4) 4
Arabic (3) 3
Bosnian (3) 3
Persian (3) 3
Lithuanian (2) 2
Romanian (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
Catalan (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2014, Volume 147, Issue 2, pp. 359 - 365.e1
Background & Aims The interferon-free regimen of ABT-450 (a protease inhibitor), ritonavir, ombitasvir (an NS5A inhibitor), dasabuvir (a non-nucleoside... 
Gastroenterology and Hepatology | IFN | PEARL-II | Ribavirin-Free | Interferon-Free Therapy | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Anilides - therapeutic use | Puerto Rico | Hepatitis C - drug therapy | United States | Anilides - adverse effects | Humans | Middle Aged | Hepacivirus - genetics | Male | RNA, Viral - blood | Viral Load | Ritonavir - adverse effects | Time Factors | Ritonavir - therapeutic use | Adult | Female | Drug Therapy, Combination | Hepacivirus - drug effects | Antiviral Agents - therapeutic use | Europe | Ribavirin - therapeutic use | Uracil - therapeutic use | Genotype | Treatment Outcome | Macrocyclic Compounds - adverse effects | Biomarkers - blood | Macrocyclic Compounds - therapeutic use | Hepatitis C - diagnosis | Uracil - adverse effects | Sulfonamides - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Sulfonamides - adverse effects | Carbamates - adverse effects | Hepacivirus - growth & development | Aged | Carbamates - therapeutic use | Uracil - analogs & derivatives | Medical colleges | Care and treatment | Proteases | Ritonavir | Biological products industry | Genetic aspects | Biological response modifiers | Hepatitis C virus | Hepatitis C | Health aspects | Ribavirin | Index Medicus | Abridged Index Medicus
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 01/2015, Volume 148, Issue 1, pp. 108 - 117
Background & Aims Interferon alfa–based regimens used to treat recurrent hepatitis C virus (HCV) infection after liver transplantation are poorly tolerated,... 
Gastroenterology and Hepatology | Antiviral Agent | Clinical Trial | DAA | NS5B Polymerase Inhibitor | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Recurrence | Prospective Studies | Antiviral Agents - pharmacokinetics | Hepatitis C - drug therapy | Liver Transplantation - adverse effects | United States | Humans | Drug Resistance, Viral | Hepacivirus - genetics | Hepacivirus - pathogenicity | Male | RNA, Viral - blood | Viral Load | Time Factors | Ribavirin - pharmacokinetics | Female | Hepatitis C - complications | Uridine Monophosphate - adverse effects | Drug Therapy, Combination | Uridine Monophosphate - therapeutic use | Hepacivirus - drug effects | Liver Neoplasms - virology | Liver Cirrhosis - diagnosis | Antiviral Agents - therapeutic use | Carcinoma, Hepatocellular - diagnosis | Ribavirin - therapeutic use | Carcinoma, Hepatocellular - surgery | Genotype | Liver Neoplasms - surgery | Treatment Outcome | Carcinoma, Hepatocellular - virology | Biomarkers - blood | Spain | New Zealand | Hepatitis C - diagnosis | Pilot Projects | Liver Cirrhosis - virology | Liver Neoplasms - diagnosis | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Liver Cirrhosis - surgery | Uridine Monophosphate - pharmacokinetics | Sofosbuvir | Virus diseases | Relapse | Liver | Transplantation | Biological response modifiers | Drug therapy | Hepatitis C virus | Health aspects | Immunosuppressive agents | Ribavirin | Diseases | Index Medicus | Abridged Index Medicus
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 11/2015, Volume 149, Issue 6, pp. 1454 - 1461.e1
Journal Article
The New England journal of medicine, ISSN 1533-4406, 05/2014, Volume 370, Issue 20, pp. 1879 - 1888
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2009, Volume 360, Issue 18, pp. 1839 - 1850
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 01/2016, Volume 62, Issue 1, pp. 32 - 36
Journal Article
The New England journal of medicine, ISSN 1533-4406, 05/2013, Volume 368, Issue 20, pp. 1867 - 1877
Journal Article
The New England journal of medicine, ISSN 1533-4406, 05/2014, Volume 370, Issue 20, pp. 1889 - 1898
Journal Article
PLoS neglected tropical diseases, ISSN 1935-2735, 05/2014, Volume 8, Issue 5, pp. e2804 - e2804
Background: Mice lacking the type I interferon receptor (IFNAR(-/-) mice) reproduce relevant aspects of Crimean-Congo hemorrhagic fever (CCHF) in humans,... 
Infectious Diseases | Parasitology | Life Sciences & Biomedicine | Science & Technology | Tropical Medicine | Liver - virology | Liver - pathology | Antiviral Agents - toxicity | Pyrazines - administration & dosage | Hemorrhagic Fever, Crimean - virology | Cercopithecus aethiops | Male | Pyrazines - therapeutic use | Indoles - administration & dosage | Liver - immunology | Amides - toxicity | Pyrazines - toxicity | Ribavirin - administration & dosage | Female | Indoles - pharmacology | Receptor, Interferon alpha-beta - genetics | Vero Cells | Hemorrhagic Fever, Crimean - drug therapy | Disease Models, Animal | Amides - pharmacology | Antiviral Agents - pharmacology | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Indoles - toxicity | Mice, Transgenic | Amides - therapeutic use | Antiviral Agents - administration & dosage | Liver - chemistry | Animals | Hemorrhagic Fever Virus, Crimean-Congo - drug effects | Ribavirin - toxicity | Indoles - therapeutic use | Mice | Pyrazines - pharmacology | Amides - administration & dosage | Ribavirin - pharmacology | Animal experimentation | Antiviral agents | Usage | Patient outcomes | Crimean hemorrhagic fever | Research | Drug therapy | Health aspects | Ribavirin | Index Medicus | Pathology | Enzymes | Mutagenesis | Rodents | Fatalities | Viruses | Infections | RNA polymerase | Experiments | Fever | Immune system
Journal Article